Printer Friendly

Nippon Organon to Release Recombinant Follicle Stimulating Hormone Follistim.

Tokyo, Japan, Aug 8, 2005 - (JCNN) - Nippon Organon will launch Follistim 75 and Follistim 150, its proprietary recombinant follicle stimulating hormone (FSH) products used in assisted reproductive treatment, on August 11.

The new products will be the first recombinant FSH agents to be marketed in Japan.

Compared to the conventional urine-derived FSH agent, Follistim has a purity of 99% and improves the pregnancy rate.

The new products are not to be covered by the National Health Insurance.

Source: JCN

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Aug 9, 2005
Previous Article:Sankyo's Antihypertensive Agent, ARB Olmesartan to Be Available in Central and South America.
Next Article:Asahi Breweries to Start Experimental Study of Biomass Ethanol Using High Biomass Sugarcane.

Related Articles
Con(tra)ception: hormonal coin toss.
Keeping sex under control.
Hormone-blockers may yield male 'pill.' (developing gonadotropin-releasing hormone as a contraceptive)
Follicle size matters: hormone regimen may reduce pregnancy success.
Shionogi, Nippon Kayaku Receive Approval for Cetrotide.
Shionogi, Nippon Kayaku to Release Cetrotide.
Nippon Kayaku, Shionogi Release Cetrotide, Premature Ovulation Inhibitor, in Japan.
Man's worst friend? TCDD and male reproductive effects.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |